CONGRESS GUIDE
05.09.2016 • Views
Share Embed Flag

CONGRESS GUIDE

ExportFinalProgram_26082016041327

ExportFinalProgram_26082016041327

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
thromboadviser

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

ERS International Congress 2016<br />

DETAILED PROGRAMME<br />

TUESDAY 06 SEPTEMBER, 2016<br />

OA3331<br />

OA3332<br />

OA3333<br />

OA3334<br />

OA3335<br />

OA3336<br />

OA3337<br />

LATE-BREAKING ABSTRACT: Long-term consequences of central airways stenosis after lung transplantation<br />

Michele Porzio (Strasbourg, France), Michele Porzio, Andrea Mazzetta, Romain Kessler, Anne Olland<br />

The influence of extracorporeal photopheresis on NF B signaling and cytokine expression in lung transplant<br />

patients<br />

Linda Langehegermann (Essen, Germany), Linda Langehegermann, Ilona Spyra, Vasiliki Besa, Björn E. Kleibrink, Gerhard<br />

Weinreich, Helmut Teschler, Uwe Hillen, Bastian Schilling, Cindy Franklin, Sabine Meyer, Esra Alabas, Markus Kamler,<br />

Peter A. Horn, Vera Rebmann, Urte Sommerwerck<br />

Inflammatory response following DCD and DBD lung transplantation<br />

Rosalba Romano (Harefield, United Kingdom), Rosalba Romano, Louit Thakuria, Shirin Sheibani, Fabio De Robertis,<br />

Aron-Frederik Popov, Mohamed Amrani, Toufan Bahrami, Paras Dalal, Simona Soresi, Martin Carby, Anna Reed, Andre<br />

Simon, Nandor Marczin, Harefield POPSTAR Group<br />

Intra tracheal instillation of BMSC-cm attenuate acute rejection in rat lung allotransplantation<br />

Jaroslaw Pierog (Szczecin, Poland), Jaroslaw Pierog, Luca Tamo, Gregor Kocher, Richard Fakin, Mathias Gugger, Tomasz<br />

Grodzki, Thomas Geiser, Amiq Gazdhar, Ralph Alexander Schmid<br />

Epithelial-mesenchymal transition in chronic lung allograft dysfunction. Role of leucocyte microparticles<br />

Benjamin Renaud-Picard (STRASBOURG, France), Benjamin Renaud-Picard, Justine Toussaint, Fatiha El Ghazouani,<br />

Florence Toti, Laurence Kessler, Romain Kessler<br />

Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung<br />

transplantation<br />

Domenica Federica Briganti (Borgarello, Italy), Domenica Federica Briganti, Beatrice Aramini, Carla Kim, Robin Chan,<br />

Bowen Zhou, Somwmya Sreekanth, Kashif Raza, Hilary Robbins, Lori Shah, Selim Arcasoy, Joshua Sonett, Federica<br />

Meloni, Gilbert Di Paolo, Frank D’Ovidio<br />

A post-hoc analysis of donor lungs declined for transplantation<br />

Stijn Verleden (Leuven, Belgium), Stijn Verleden, An Martens, Tobias Heigl, Hannelore Bellon, Elly Vandermeulen, Robin<br />

Vos, Johny Verschakelen, Walter Coudyzer, Dirk Van Raemdonck, Arne Neyrinck, Bart Vanaudenaerde<br />

OA3338<br />

Long-term kinetics of CD19+CD24 high CD38 high Breg cells in lung transplant recipients<br />

Davide Piloni (PAVIA, Italy), Davide Piloni, Monica Morosini, Sara Magni, Alice Balderacchi, Emanuela Cova, Simona<br />

Inghilleri, Andrea Maria D’Armini, Luigia Scudeller, Filippo Antonacci, Tiberio Oggionni, Federica Meloni<br />

Room K Session 531 08:30 - 10:30<br />

Oral Presentation: Therapeutic trials in lung cancer<br />

Chairs : Jacques Cadranel (Paris, France), Achim Rittmeyer (Immenhausen, Germany)<br />

OA6010<br />

Introduction: The role of the respiratory physician in therapeutic trials in lung cancer<br />

Achim Rittmeyer (Immenhausen, Germany)<br />

OA3339<br />

OA3340<br />

OA3341<br />

OA3342<br />

OA3343<br />

OA3344<br />

Co-expression of S100A14 and S100A16 is a predictive marker for platinum-based adjuvant chemotherapy in<br />

resected lung adenocarcinomas<br />

KEN KATONO (KANAGAWA, Japan), Ken Katono, Yuichi Sato, Shinichiro Ryuge, Ryo Nagashio, Masanori Yokoba,<br />

Masato Katagiri, Kazu Shiomi, Yukitoshi Satoh, Noriyuki Masuda<br />

24h-blood profile gene expression biomarkers of the response to bevacizumab-erlotinib (BE) in advanced nonsquamous<br />

non-small cell lung cancer (NSCLC)<br />

Florent Baty (St. Gallen, Switzerland), Florent Baty, Martin Früh, Markus Jörger, Martin Brutsche<br />

Gefitinib versus erlotinib as first-line treatment in EGFR mutant advanced lung adenocarcinoma<br />

Chai Chee Shee (Petaling Jaya, Malaysia), Chai Chee Shee, Liam Chong Kin, Pang Yong Kek, Kow Keng Siong, Poh Mau<br />

Ern, Wong Chee Kuan, Tan Jiunn Liang<br />

Afatinib (A) vs gefitinib (G) as first-line treatment (tx) for patients (pts) with EGFR mutation-positive (EGFRm+)<br />

NSCLC: LUX-Lung 7<br />

Vera Hirsh (Montréal, QC, Canada), Vera Hirsh, Keunchil Park, Eng-Huat Tan, Li Zhang, Kenneth O’Byrne, Michael<br />

Boyer, James Chih-Hsin Yang, Tony Mok, Jean Fan, Dan Massey, Luis Paz-Ares<br />

A case series of eight patients treated with alectinib including a case of interstitial lung disease<br />

Yoshihiko Sakata (Kumamoto, Japan), Yoshihiko Sakata, Kodai Kawamura, Yuko Yasuda, Naoki Shingu, Keisuke Anan,<br />

Kazuya Ichikado<br />

A phase II trial of lipoplatin and gemcitabine in patients with NSCLC previously treated with platinum-based<br />

chemotherapy<br />

Marios E. Froudarakis (Alexandroupolis, Greece), Konstantinos Kaltsas, Stavros Anevlavis, Athanasia Pataka, Georgios<br />

Kouliatsis, Sofia Pozova, Demosthenes Bouros, Marios Froudarakis<br />

223 26.08.2016

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!